Last reviewed · How we verify
Etravirine; Lopinavir; Ritonavir
Etravirine; Lopinavir; Ritonavir is a Small molecule drug developed by Tibotec Pharmaceuticals, Ireland. It is currently in Phase 1 development.
At a glance
| Generic name | Etravirine; Lopinavir; Ritonavir |
|---|---|
| Sponsor | Tibotec Pharmaceuticals, Ireland |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Study of Cobicistat-Boosted Atazanavir (ATV/co), Cobicistat-Boosted Darunavir (DRV/co) and Emtricitabine/Tenofovir Alafenamide (F/TAF) in Children With HIV (PHASE2, PHASE3)
- Trial to Evaluate the Interest of a Reductive Anti Retroviral Strategy Using Dual Therapy Inspite of Triple Therapy (PHASE3)
- Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy
- Study to Evaluate Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Fixed Dose Combination (FDC) in Virologically-Suppressed HIV-1 Infected Adults Harboring the Archived Isolated NRTI Resistance Mutation M184V/M184I (PHASE3)
- Switching From a Tenofovir Disoproxil Fumarate (TDF) Containing Regimen to Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Alafenamide (E/C/F/TAF) Fixed-Dose Combination (FDC) in Virologically-Suppressed, HIV-1 Infected Adults Aged ≥ 60 Years (PHASE3)
- Safety and Efficacy of Switching From Regimens of ABC/3TC + a 3rd Agent to E/C/F/TAF Fixed-Dose Combination (FDC) in Virologically-Suppressed HIV 1 Infected Adults (PHASE3)
- Kaletra in Combination With Antiretroviral Agents
- A Pilot Study of Kaletra and Intelence Tablets in Naive Subjects (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Etravirine; Lopinavir; Ritonavir CI brief — competitive landscape report
- Etravirine; Lopinavir; Ritonavir updates RSS · CI watch RSS
- Tibotec Pharmaceuticals, Ireland portfolio CI
Frequently asked questions about Etravirine; Lopinavir; Ritonavir
What is Etravirine; Lopinavir; Ritonavir?
Etravirine; Lopinavir; Ritonavir is a Small molecule drug developed by Tibotec Pharmaceuticals, Ireland.
Who makes Etravirine; Lopinavir; Ritonavir?
Etravirine; Lopinavir; Ritonavir is developed by Tibotec Pharmaceuticals, Ireland (see full Tibotec Pharmaceuticals, Ireland pipeline at /company/tibotec-pharmaceuticals-ireland).
What development phase is Etravirine; Lopinavir; Ritonavir in?
Etravirine; Lopinavir; Ritonavir is in Phase 1.